These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30099947)

  • 1. Hyperinflation: Definitions and Causes.
    Saltiel M; Finnefrock M
    J Pharm Pract; 2020 Apr; 33(2):183-186. PubMed ID: 30099947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperinflation-Definitions and Causes.
    Saltiel M; Finnefrock M
    J Pharm Pract; 2018 Aug; 31(4):370-373. PubMed ID: 29905083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Evolution of Supply and Demand in Markets for Generic Drugs.
    Frank RG; McGuire TG; Nason I
    Milbank Q; 2021 Sep; 99(3):828-852. PubMed ID: 34075623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Who's really raising drug prices?
    Zagorin A
    Time; 1999 Mar; 153(9):46-8. PubMed ID: 10346086
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased topical generic prices by manufacturers.
    Bhatt MD; Bhatt BD; Dorrian JT; McLellan BN
    J Am Acad Dermatol; 2019 May; 80(5):1353-1357. PubMed ID: 29544742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Contribution Of New Product Entry Versus Existing Product Inflation In The Rising Costs Of Drugs.
    Hernandez I; Good CB; Cutler DM; Gellad WF; Parekh N; Shrank WH
    Health Aff (Millwood); 2019 Jan; 38(1):76-83. PubMed ID: 30615532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Market Competition and Prices of Generic Topical Dermatology Drugs.
    Li DG; Joyce C; Mostaghimi A
    JAMA Dermatol; 2018 Dec; 154(12):1441-1446. PubMed ID: 30383117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of generic substitution on price competition in Finland.
    Aalto-Setälä V
    Eur J Health Econ; 2008 May; 9(2):185-91. PubMed ID: 17508226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Drug Shortages and Association with Generic Drug Prices: A Retrospective Cohort Study.
    Dave CV; Pawar A; Fox ER; Brill G; Kesselheim AS
    Value Health; 2018 Nov; 21(11):1286-1290. PubMed ID: 30442275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generic drug prices and policy in Australia: room for improvement? a comparative analysis with England.
    Mansfield SJ
    Aust Health Rev; 2014 Feb; 38(1):6-15. PubMed ID: 24480618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effects of the New Methodology Application on the Method of Pricing of Drugs-The Case of the Republic of Macedonia.
    Zareski R; Kapedanovska Nestorovska A; Grozdanova A; Dimitrova B; Suturkova LJ; Sterjev Z
    Value Health Reg Issues; 2016 Sep; 10():19-28. PubMed ID: 27881273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Projecting future drug expenditures--1993.
    Santell JP
    Am J Hosp Pharm; 1993 Jan; 50(1):71-7. PubMed ID: 8427283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing the Lack of Competition in Generic Drugs to Improve Healthcare Quality and Safety.
    Sivashanker K; Fanikos J; Kachalia A
    J Gen Intern Med; 2018 Nov; 33(11):2005-2007. PubMed ID: 30091120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New generic pricing scheme maintains high prices and risks of shortages.
    Morgan SG; Persaud N
    CMAJ; 2018 Apr; 190(14):E410-E411. PubMed ID: 29632033
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in Retail Prices of Prescription Dermatologic Drugs From 2009 to 2015.
    Rosenberg ME; Rosenberg SP
    JAMA Dermatol; 2016 Feb; 152(2):158-63. PubMed ID: 26606197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Projecting future drug expenditures--1994.
    Santell JP
    Am J Hosp Pharm; 1994 Jan; 51(2):177-87. PubMed ID: 8160668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OSTEOPOROSIS DRUGS MARKETED IN THE UNITED STATES: GENERIC COMPETITION, PRICING STRUCTURE, AND DISPERSION AMONG PAYERS.
    Balkhi B; Seoane-Vazquez E; Rodriguez-Monguio R
    Int J Technol Assess Health Care; 2016 Jan; 32(6):385-392. PubMed ID: 28065194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending.
    Wouters OJ; Kanavos PG; McKEE M
    Milbank Q; 2017 Sep; 95(3):554-601. PubMed ID: 28895227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Price regulation and generic competition in the pharmaceutical market.
    Dalen DM; Strøm S; Haabeth T
    Eur J Health Econ; 2006 Sep; 7(3):208-14. PubMed ID: 16841230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Projecting future drug expenditures--1992.
    Ensor PA
    Am J Hosp Pharm; 1992 Jan; 49(1):140-5. PubMed ID: 1570858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.